FDA NDC Directory · JSON-LD · Markdown

Meloxicam

NDC 71740-339 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAvondale Pharmaceuticals, LLC
Marketing categoryNew Drug Application (innovator) · App NDA021530
Dosage form / routeSUSPENSION · ORAL
Active ingredientsMELOXICAM (7.5 mg/5mL)
Marketing started20051101
Package count1

External sources

Source: openFDA. Public-domain (CC0).